MedTrace Logo

Dysport in the Treatment of Glabellar Lines in Chinese Subjects

NCT02450526 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 520

Last updated 2019-08-06

Study results available
· View outcomes & findings →

Summary

The objective of this study is to demonstrate the efficacy of Dysport for the improvement in appearance of moderate to severe glabellar lines and to assess the short term and long term safety of Dysport, used for the improvement in appearance of moderate to severe glabellar lines in Chinese subjects.

Conditions

  • Glabellar Lines

Interventions

BIOLOGICAL

Botulinum toxin type A

BIOLOGICAL

Botulinum toxin type A

DRUG

Placebo

50 Units

DRUG

Placebo

20 Units

Sponsors & Collaborators

Principal Investigators

  • Ipsen Study Director, M.D. · Ipsen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-07-31
Completion
2017-09-06

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02450526 on ClinicalTrials.gov